Timboligue, Bernadette M.

HRN: 28-56-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/11/2026
03/18/2026
ORAL
3cc
BID
Oral Candidiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines